Production (Stage)
Integrated Biopharma, Inc.
INBP
$0.292
$0.0020.69%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 426.72% | -55.21% | -3.36% | -5.96% | 174.61% |
| Total Depreciation and Amortization | -4.40% | -0.63% | 0.95% | 4.28% | 0.66% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 106.40% | -50.59% | 82.01% | -2.11% | 1,677.78% |
| Change in Net Operating Assets | -55.59% | -104.57% | 80.77% | -199.78% | 152.47% |
| Cash from Operations | 206.47% | -69.41% | 453.23% | -111.32% | 189.93% |
| Capital Expenditure | -300.00% | 48.21% | 61.64% | 57.68% | -1,337.50% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -300.00% | 48.21% | 61.64% | 57.68% | -1,337.50% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 100.00% | 36.36% | -10.00% | 9.09% |
| Issuance of Common Stock | -100.00% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -100.00% | 357.14% | 36.36% | -10.00% | 9.09% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 163.16% | -68.01% | 273.18% | -126.63% | 169.17% |